C63 - Resident Basic Science II: Neuropharmacology
| Event Time: | Sunday May 5, 2019 1:00 pm to 5:30 pm |
| Topic(s): | Research Methodology, Education, and History, Academic, Foundations in Clinical Neurology for APPs |
| Director(s): | James Owens MD, PhD |
| Description: | Neurology now has an "embarrassment of riches" when it comes to pharmacological treatment. As our understanding of the basic neurobiology of disease progresses, this pharmacopeia continues to expand and to involve novel agents. Faculty will review basic pharmacological principles important for medication selection as well as facilitate an expanded understanding of the treatment of epilepsy, movement disorders, and sleep disorders. Presentations will include discussion of drug targets and mechanisms punctuated by illustrative cases. This program complements Resident Basic Science I: Neuropathology and Resident Basic Science III: Neuroanatomy: All the Lesions, but covers independent topics. |
| Completion Message: | Participants should be able to discuss basic pharmacological concepts relevant to the clinical practice of neurology as well as an approach to medication selection for patients with epilepsy, movement disorders, and sleep disorders based on an understanding of pharmacological mechanisms of action and pharmacokinetcs. |
| CME Credits: | 4.25 |
| Core Competencies: | Medical Knowledge |
| Start/End Time | Title | Faculty |
|---|---|---|
| 1:00 PM - 1:05 PM | Introduction | James W. M. Owens MD, PhD |
| 1:05 PM - 1:50 PM | Overview of Neuropharmacology | James W. M. Owens MD, PhD |
| 1:50 PM - 2:35 PM | Treatment of Epilepsy | Atul Maheshwari MD |
| 2:35 PM - 2:45 PM | Break | Faculty |
| 2:45 PM - 3:30 PM | Treatment of Parkinson's Disease | Joohi Jimenez Shahed MD |
| 3:30 PM - 4:15 PM | Treatment of Sleep Disorders | James W. M. Owens MD, PhD |
| 4:15 PM - 4:25 PM | Break | Faculty |
| 4:25 PM - 5:10 PM | Treatment of Multiple Sclerosis | James M. Stankiewicz MD, FAAN |
| 5:10 PM - 5:30 PM | Questions and Answers | Faculty |
| Speaker | Disclosure |
|---|---|
| Joohi Jimenez Shahed, MD | Dr. Jimenez Shahed has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with St. Jude Medical/Abbott, Medtronic, Teva, Bracket, Nuvelution, Sunovion,. Dr. Jimenez Shahed has received research support from Biotie/Accorda, Medtronic, St. Jude Medical/Abbott, Eli Lilly & Company, Wilsons Therapeutics. |
| Atul Maheshwari, MD | Dr. Maheshwari has nothing to disclose. |
| James W. M. Owens, Jr., MD, PhD | Dr. Owens has received personal compensation in an editorial capacity for the journal Neurology and Continuum. |
| James M. Stankiewicz, MD, FAAN | Dr. Stankiewicz has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Genentech, Biogen, Novartis, EMD Serono, Genzyme, Celgene, and Bayer. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-7:30 AM |
|---|
|
Grant Writing 101: Getting Started
Logan Schneider MD |
| 7:00 AM-9:00 AM |
|
C247 -
What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders
Stephanie Nahas MD, FAAN |
|
C249 -
Clinical Pearls: Learning from Complex Cases Simple Lessons that Apply to Everyday Problems
S. Josephson MD, FAAN |
| 8:00 AM-8:30 AM |
|
How to Put Together an Effective Research Presentations
Enrique Leira MD, MS, FAAN |
| 8:00 AM-8:45 AM |
|
How to Give Effective Feedback
Adnan Subei DO, Diana Barratt MD, MPH, FAAN, Maryam Shakir MPH, Jill Liebman DO, Farah Fourcand MD |
| 1:00 PM-1:45 PM |
|
Growing Research in Medical Marijuana
Anup Patel MD, FAAN |
|
Racial, Ethnic, and Gender Disparities in Early and Mid-Career
Michelle Mauermann MD, FAAN |